Disease | lymphoma, non-hodgkin |
Phenotype | C0019158|hepatitis |
Sentences | 2 |
PubMedID- 24060287 | Bendamustine and rituximab for indolent b-cell non-hodgkin lymphoma in patients with compensated hepatitis c cirrhosis: a case series. |
PubMedID- 21188204 | In a recently published review of 160 chronic hepatitis c patients with non-hodgkin lymphoma, twenty-four (15%) of them developed significant liver toxicity during chemotherapy [14]. |
Page: 1